Is Combined Angiotensin-converting Enzyme Inhibition and Angiotensin Receptor Blockade Associated with Increased Risk of Cardiovascular Death in Hemodialysis Patients?

By  

Current Hypertension Reviews, Vol. 8, Iss. 4, 2012-11 ,pp. : 256-266

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease

By Omae Kiyotsugu   Ogawa Tetsuya   Nitta Kosaku  

Heart and Vessels, Vol. 25, Iss. 3, 2010-05 ,pp. : 203-208

Springer Publishing Company

Access to resources Recommend Favorite

Angiotensin-converting enzyme inhibitors: ischemia is not the correct measure of benefit

By Anderson H.V.  

Journal of the American College of Cardiology, Vol. 42, Iss. 12, 2003-12 ,pp. : 2060-2062

Elsevier

Access to resources Recommend Favorite

The appropriate dose of angiotensin‐converting‐enzyme inhibitors or angiotensin receptor blockers in patients with dilated cardiomyopathy. The higher, the better?

By  

ESC HEART FAILURE, Vol. 2, Iss. 4, 2015-12 ,pp. : 103-105

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early sign of atherosclerosis in slow coronary flow and relationship with angiotensin-converting enzyme I/D polymorphism

By Tanriverdi Halil   Evrengul Harun   Mergen Hatice   Acar Ceren   Seleci Deniz   Kuru Omur   Tanriverdi Seyhan   Kaftan Asuman  

Heart and Vessels, Vol. 22, Iss. 1, 2007-01 ,pp. : 1-8

Springer Publishing Company

Access to resources Recommend Favorite